New research published in the Journal of Leukocyte Biology suggests that a decrease in classical blood monocytes, coupled with an increase in certain macrophages may lead to therapeutic targets for Crohn's diseaseFor those coping with Crohn's disease, a new research report published in the Journal of Leukocyte Biology offers hope for the development of new and more effective drugs. In the report, scientists show for the first time, precisely what type of immune cells are involved in driving the inflammation process in the disease.
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment